PI
PIII.US P3 Health Partners Inc
- Market cap
- USD 560M
- P/E
- -
- P/B
- 0.62x
- ROE
- 30.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is PIII.US undervalued?
Graham numberThe Graham number of P3 Health Partners Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
P3 Health Partners Inc fundamental analysis
No fundamental analysis for P3 Health Partners Inc yet.
P3 Health Partners Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About P3 Health Partners Inc
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
Full company profileP3 Health Partners Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
P3 Health Partners Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 87.7M | 145M | 491M | - | 1.05B | 1.27B | 1.50B | 1.46B | 1.56B |
| Gross Profit | 87.7M | 145M | 491M | - | 1.05B | 1.27B | 1.50B | -144M | 682M |
| Operating Income | -49.7M | -39.5M | -28.6M | - | -1.56B | -168M | -313M | -270M | 96.6M |
| EBITDA | -49.4M | -39.0M | -28.1M | - | -1.46B | -81.1M | -198M | -182M | 177M |
| Net Income | -43.8M | -42.0M | -31.4M | - | -270M | -57.8M | -136M | -148M | 32.4M |
| EPS | -92 | -88 | -40 | - | -325 | -30 | -46 | -45 | 4.89 |
| Balance Sheet | |||||||||
| Total Assets | - | 65.6M | 106M | 2.36B | 877M | 861M | 783M | 657M | 670M |
| Total Liabilities | - | 122M | 237M | 300M | 354M | 427M | 634M | 797M | 469M |
| Shareholders' Equity | - | -42.1M | -130M | 2.06B | 5.85M | 142M | 75.9M | -155M | 107M |
| Cash & Short-term Investments | - | 32.6M | 36.3M | 140M | 18.5M | 36.3M | 38.8M | 25.0M | 43.9M |
| Total Debt | - | 22.7M | 51.3M | 89.9M | 108M | 125M | 166M | 285M | 132M |
| Cash Flow | |||||||||
| Operating Cash Flow | -29.2M | -28.3M | -24.6M | -66.5M | -126M | -76.0M | -110M | -91.2M | -120M |
| Capital Expenditure | 3.31M | 1.45M | 2.93M | 3.41M | 2.23M | 1.83M | 0.00 | 79.0K | 0.00 |
| Free Cash Flow | -32.5M | -29.7M | -27.5M | - | -128M | -77.9M | -110M | -91.3M | -120M |
| Ratios | |||||||||
| ROE | - | - | - | - | -4,614.4% | -40.6% | -178.9% | - | 30.2% |
| ROA | - | -64.0% | -29.5% | - | -30.8% | -6.7% | -17.3% | -22.5% | 4.8% |
| Net Profit Margin | -49.9% | -28.8% | -6.4% | - | -25.7% | -4.6% | -9.1% | -10.1% | 2.1% |
| Debt to Equity | - | - | - | 0.04x | 18.37x | 0.88x | 2.19x | - | 1.23x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
P3 Health Partners Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 180K | 0.23 | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:50 on Apr 14, 2025.
Who owns P3 Health Partners Inc
- Insiders 48.38%
- Institutions 8.18%
- Public & others 43.44%
- Shares outstanding 4.02M
- Free float 2.29M
Top funds holding PIII.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 28.4K | 0.71% | 0.00% | Sep 2026 |
| Fidelity Extended Market Index | 7.56K | 0.19% | -0.21% | Sep 2026 |
| Fidelity Total Market Index | 3.21K | 0.08% | 0.00% | Sep 2026 |
| Fidelity Series Total Market Index | 2.24K | 0.06% | 0.00% | Sep 2026 |
| Fidelity Nasdaq Composite Index | 1.28K | 0.03% | 0.00% | Aug 2026 |
| Vanguard U.S. Eq Idx £ Acc | 308.00 | 0.01% | 0.00% | Sep 2026 |
| Knights of Columbus U.S. All Cap Idx I | 3.00 | 0.00% | -62.50% | Sep 2026 |
Top institutions holding PIII.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| HRT FINANCIAL LLC | 54.7K | 1.36% | +262.56% | Jun 2026 |
| Jane Street Group LLC | 54.5K | 1.36% | 0.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 41.5K | 1.03% | -41.26% | Jun 2026 |
| MYDA Advisors LLC | 20.0K | 0.50% | 0.00% | Jun 2026 |
| CI Private Wealth LLC | 19.7K | 0.49% | -0.50% | Jun 2026 |
| Geode Capital Management, LLC | 17.1K | 0.43% | -33.99% | Jun 2026 |
| Scientech Research LLC | 16.3K | 0.41% | 0.00% | Jun 2026 |
| Abundance Wealth Counselors | 16.0K | 0.40% | 0.00% | Jun 2026 |
| Diversified Trust Co | 13.4K | 0.33% | -33.85% | Jun 2026 |
| Renaissance Technologies Corp | 12.5K | 0.31% | -17.16% | Sep 2026 |
| BlackRock Inc | 7.64K | 0.19% | -30.06% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 6.48K | 0.16% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 2.82K | 0.07% | 0.00% | Jun 2026 |
| UBS Group AG | 2.33K | 0.06% | +26.52% | Jun 2026 |
| Tower Research Capital LLC | 540.00 | 0.01% | 0.00% | Jun 2026 |
| Vanguard Global Advisers, LLC | 308.00 | 0.01% | 0.00% | Jun 2026 |
| Royal Bank of Canada | 298.00 | 0.01% | 0.00% | Jun 2026 |
| Efficient Wealth Management LLC | 45.00 | 0.00% | 0.00% | Jun 2026 |
| BNP Paribas Arbitrage, SA | 36.00 | 0.00% | 0.00% | Jun 2026 |
| JPMorgan Chase & Co | 19.00 | 0.00% | 0.00% | Jun 2026 |
P3 Health Partners Inc company profile
- Company name
- P3 Health Partners Inc
- Ticker
- PIII.US
- Exchange
- USA Stocks
- Listed since
- Apr 6, 2021
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 320
- Fiscal year end
- December
- Address
- 2370 Corporate Circle, Henderson, NV, United States, 89074
- Phone
- 702 910 3950
- Website
- p3hp.org
About P3 Health Partners Inc
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
P3 Health Partners Inc management
10- Dr. Aric Coffman M.D.CEO, President & Director · born 1974
- Dr. Amir Bacchus M.B.A., M.D.Co-Founder, Chief Medical Officer & Director · born 1965
- Mr. Leif PedersenChief Financial Officer · born 1976
- Mr. William BettermannExecutive VP & COO
- Mr. Devery GoodeySenior Vice President of Technology
- Ms. Sarah Bussmann B.S.N., CRNI, M.H.A., R.N.Chief Administrative Officer
- Mr. William HooverInvestor Relations Officer
- Mr. Todd M. SmithChief Legal Officer, Chief Compliance Officer & Corporate Secretary
- Ms. Shelly MartinRegional President of Nevada & Arizona
- Ms. Erin MastagniMarket President of Oregon